ACTBL2 and ovarian serous adenocarcinoma: In line with the obtained results concerning the total cohort, an infiltration by ACTBL2-positive leukocytes was identified as a statistically independent prognostic marker for the overall survival of patients with low-grade serous ovarian cancer (HR = 0.058, p = 0.018).